Trial Profile
Effects of Replacing Lantus With Basalin on the Glycemic Variation in Patients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Aug 2020
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 09 Jun 2019 Planned End Date changed from 30 Jan 2019 to 30 Jul 2019.
- 09 Jun 2019 Status changed from not yet recruiting to recruiting.
- 23 Aug 2018 New trial record